{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:17:12Z","timestamp":1790806632678,"version":"4.1.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate-specific membrane antigen (PSMA) PET\/CT has become an unparalleled modality in the diagnosis of primary and recurrent prostatic adenocarcinoma, often revealing sites of disease that were previously invisible on conventional imaging. In this 78-year-old man with suspected prostate cancer recurrence, PSMA PET\/CT revealed focal radiotracer uptake in the brain, which would ordinarily raise suspicion for metastases, but was a false positive in the setting of a recent stroke. Increased PSMA uptake has been reported in subacute infarcts and primary and secondary brain tumors. Careful history and comparison with prior imaging are vital to avoid false-positive diagnosis in such patients.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005373","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T05:00:06Z","timestamp":1720414806000},"page":"882-883","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Subacute Cerebral Infarct"],"prefix":"10.1097","volume":"49","author":[{"given":"Vaibhav","family":"Jain","sequence":"first","affiliation":[{"name":"Neuroradiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacey","family":"McIntosh","sequence":"additional","affiliation":[{"name":"Oncologic and Molecular Imaging, Department of Radiology, UMass Chan Medical School, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.3390\/cancers14153638","article-title":"The role of PSMA PET\/CT in the primary diagnosis and follow-up of prostate cancer\u2014a practical clinical review","volume":"14","year":"2022","journal-title":"Cancers (Basel)"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1097\/RLU.0000000000001291","article-title":"Subacute stroke mimicking cerebral metastasis in 68Ga-PSMA-HBED-CC PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/RLU.0000000000001489","article-title":"Subacute cortical infarct showing uptake on 68Ga-PSMA PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/RLU.0000000000004798","article-title":"Incidental uptake in a subacute stroke on 18F-piflufolastat PSMA PET\/CT","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"5358545","DOI":"10.1155\/2022\/5358545","article-title":"Prostate-specific membrane antigen as target for neuroimaging of central nervous system tumors","volume":"2022","year":"2022","journal-title":"Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","year":"2020","journal-title":"Cancer Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/RLU.0000000000005126","article-title":"A hangover under 177Lu-PSMA-617 therapy: a red flag for brain 68Ga-PSMA-11 PET\/MRI?","volume":"49","year":"2024","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1097\/RLU.0000000000005011","article-title":"Late subacute cerebral hematoma mimicking a metastasis on PSMA PET\/CT","volume":"49","year":"2024","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/RLU.0000000000004777","article-title":"PSMA uptake in a subdural hematoma","volume":"48","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:02:44Z","timestamp":1750532564000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005373"}},"subtitle":["An Unusual Cause of Radiotracer Uptake at 18F-PSMA PET\/CT"],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005373","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}